- Staat
- TN
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 27.01.2023
- Impfdatum
- 24.01.2023
- Beginn
- 26.01.2023
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Blood glucose normal
Blood thyroid stimulating hormone
Dizziness
Dyspnoea
Electrocardiogram normal
Flushing
Full blood count normal
Gait disturbance
Loss of consciousness
Metabolic function test
Syncope
Unresponsive to stimuli
Urine analysis normal
Vision blurred
Symptomtext
Pt had 2 syncopal episodes at work early on morning of 1/26 (works overnight shift). He became weak, dizzy, flushed, a friend helped him to the ground and he said he was passed out nearly 20 minutes. He was aware of surroundings but felt weak and couldn't respond. Had second similar episode around 7 am after reaching home. Came to clinic 10:30 am and was flushed and complaining of difficulty getting his breath and blurry vision. had normal vitals and oxygen and no swelling of lips/tongue. He had some facial flushing. He was alert and awake but weak and needed assistance walking. It is not clear if this was related to vaccination of one or both of vaccines but patient had no prior history of syncope and no apparent other changes in routine or illnesses.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- Normal ekg, glucose, urine, cbc, cmp, tsh.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 12.05.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Anxiety
Dyspnoea
Hypersensitivity
Pharyngeal swelling
Tachycardia
Wheezing
Symptomtext
Narrative: Patient was seen in ER for a severe allergic reaction after had received a dipteria/Tetnus vaccine same day earlier in the day. Prior to arrival pt c/o throat swelling and soa. EMS had given 1 shot of epi with slight relief. She was visibly anxious, and tachycardic. Scattered bilateral wheezing. Pt's vitals: hr 118 bp 113/59 sat ra 100% rr 22 PE mild wheezes bilateral given: benadryl 25mg iv x 2 duonebulizer epinephrine 0.3mg im ns bolus if 1L solu medrol 125mg iv push sent home with Rxs for: pepcid 40mg bid for 5days benadryl 25mg 1 po tid for 5 days prednisone 20 mg tab; 60mg for 3 days primary care provider posted allergy on her chard and decided from this point on no vaccines. Pt highly reactive with long list if allergies in pt's chart.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 08.04.2022
- Impfdatum
- 30.11.2021
- Beginn
- 05.01.2022
- Tage bis Beginn
- 36,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Chronic obstructive pulmonary disease
Coronavirus infection
Oxygen saturation abnormal
Pneumonia bacterial
Superinfection
Symptomtext
ED visit for abnormal pulse oximetry. admitted due to suspected COPD exacerbation secondary to coronavirus OC43 (not SARS-CoV-2) and suspected superimposed bacterial pneumonia. She received steroid, antibiotics and Bronchodilators. She also received IV Lasix 20 mg x1 due to concern for pulmonary edema. Symptoms have improved and patient insists on going home day 2. She is clinically stable for discharge at this time. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pneumonia bacterial
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 21.03.2022
- Impfdatum
- 18.03.2022
- Beginn
- 19.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Arthralgia
Headache
Hypoaesthesia
Injection site bruising
Injection site erythema
Injection site swelling
Neck pain
Pain
Pain in extremity
Paraesthesia
Symptomtext
Patent States: My arm was is in pain and it was a bright red where the shot was given. There was a big bruise and swelling the size of two golf balls. My arm was also numb and my fingers were also tingly. It hurts to lift my arm. My neck and shoulders are in pain and I have a severe headache. It also hurt to move my army up and down and my neck hurt to turn left to right. I still have a bruise and my arm is still hurts four days later. On Sunday, day two of the symptoms, I called the Nurse Hotline and I was informed to go to Urgent Care. I went to urgent care about the reaction and symptoms that I was having. They informed me that it might be Cerratis and prescribed me Docycline and informed me to go back to talk to the medical facility that prescribed the vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Neurology Chiropractor Podiatry Dermatology
- Andere Medikamente
- Pregamblin Spironolactin Sumatriptin
- Allergien
- Percoset Pollen Skin on certain Fruits (peach, apple, plums, cherries)
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 09.02.2022
- Impfdatum
- 07.01.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Injected limb mobility decreased
Insomnia
Migraine
Pain
Pain in extremity
Symptomtext
Severe left arm pain. After receiving injections patient's arm sore. Instead of soreness improving, soreness worsened. No onset date of symptoms. severe pain, unable to lift left arm, difficultly sleeping, migraines. Patient has been seen at medical office and ER for symptoms. Latest ER visit 2/9/22. patient believes she is having a reaction to the TD vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 22.12.2021
- Impfdatum
- 07.12.2021
- Beginn
- 07.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Feeling hot
Hypotension
Symptomtext
Approx one min after immunization, donor experienced lightheadedness and warmth, and hypotensive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- none
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 02.08.2023
- Impfdatum
- 28.07.2023
- Beginn
- 28.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Feeling abnormal
Immunisation
Pain in extremity
Symptomtext
Patient was given a dose of Td that was expired on 7/28/2023 @ around 12pm. When error was discovered Dr was informed. Pt was called by Dr and voicemail was left for pt to call back. Dr looked into it and said pt need to have 2nd dose of Td as soon as patient can get back to office. I called patient on 7/29/23 and advised her of the error Patient came back to the off on 7/29/23 and we readministered the Td. Vaccine was double check by nurse practitioner that was working that day. I called and followed up with patient on Sunday 7/30/23 and Monday 7/31/23 to see how she was feeling. Patient said that she felt bad just a little sore arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 01.09.2022
- Impfdatum
- 26.06.2022
- Beginn
- 27.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Acinetobacter infection
Acinetobacter test positive
Anion gap
Antinuclear antibody
Blood albumin normal
Blood calcium normal
Blood chloride normal
Blood creatinine normal
Blood glucose normal
Blood magnesium normal
Blood potassium normal
Blood sodium normal
Blood urea normal
Borrelia test negative
Breast pain
Burning sensation
C-reactive protein normal
Carbon dioxide decreased
Symptomtext
Vomiting next day. breast pain/nipple pain & hardening the full next week, left foot exploded in "athletes foot" like rash. Followed by burning and pain sensation in Right foot. Entire body aches/pain and Charlie horse like sensation throughout entire body, insomnia, muscle spasms, twitching, rash over arms, legs, feet, belly and hands. Used, heat, ice, tylenal, ibuprophen, massage therapy, stretching, sleep aids, stopped Phentermine, low dose muscle relaxer, antibiotic as tested positive for acetobacter bacterial infection, Steroid cream for rash on arms, tested for Lyme's, tick borne, and Lupus- all clear. Saw Endocrinologist, Dermatology, ER visit, Infectious Disease, and Pain Specialist.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Breast pain
- Hospital-Tage
- -
- Labordaten
- 7/21-Mayo Antinuclear Antibodies- 0.6 7/21-Magnesium-2.0 7/22-Tick Borne AB Panel- <1:64 7/21 CMP Sodium 138 Potassium 4.4 Chloride 106 Carbon Dioxide 2.4 Calcium 9.3 Alkaline 62 Aspartate 19 glucose 88 BUN 18 Creatine 0.85 Proteins 7.6 Albumin 4.0 Bilirubin 0.1 Globulin 3.6 Anion Gap 8.5 Glomerular >60 7/21 C Reactive 0.16 8/20 Suspect MIC Panel Acinetobacter Ursingii 8/21 Wound Culture Positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Depression, Empty Sella, GAD, IIH, Tinnitus, Acoustic Neuroma./Vestibular Schwannoma
- Andere Medikamente
- Folic Acid, Topiramate, Metformin, Venlafaxine, Spironolactone, Phentermine,.
- Allergien
- Sulfa, Coconut, Morphine, Povidone Iodine Added: Tetanus Toxoids now
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 16.08.2022
- Impfdatum
- 10.08.2022
- Beginn
- 12.08.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain upper
Diarrhoea
Dizziness
Symptomtext
Severe stomach cramps, diarrhea, dizziness/lightheaded
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain upper
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 03.06.2022
- Impfdatum
- 25.05.2022
- Beginn
- 26.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Malaise
Symptomtext
Pt reports that he felt sick after getting this vaccine for approximately 5 days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- Asthma, Arthritis
- Andere Medikamente
- Vitamin D, Multi Vitamin, Vitamin C, Voltaren Gel, Meloxicam, Omeprazole, Proair HFA
- Allergien
- Aspirin, Hep B Vaccine (Synthetic Vaccine)
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 14.12.2021
- Impfdatum
- 08.12.2021
- Beginn
- 09.12.2021
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Musculoskeletal stiffness
Pain
Pyrexia
Symptomtext
Approx 30-36 hrs post vaccination, donor experienced fever, stiffness, achiness, and fatigue. Donor called to tell the center on 12/14/21. She was advised to seek further medical attention.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- none
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 10.12.2021
- Impfdatum
- 08.12.2021
- Beginn
- 09.12.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Erythema
Injection site swelling
Pain
Symptomtext
36 y/o male shoulder pain. PT received T/D WED, and then on THURS pain started to get worse especially with movement. PT tried ice w/ little to no relief. PT reports egg like swelling at injection site redness was minimal. PT goal is exam, consult, and treatment plan.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.11.2023
- Impfdatum
- 26.06.2023
- Beginn
- 26.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
8 patients received the expired tenivac with no reported adverse event; Initial information received from on 14-Nov-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age and unknown gender patient who received the expired Diphtheria-2/Tetanus-5 Adsorbed Toxoids No preservative Adult [Tenivac] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 26-Jun-2023, the patient received an expired dose of suspect Diphtheria-2/Tetanus-5 Adsorbed Toxoids No preservative Adult Suspension for injection (lot U7092AA, Expiry date: 24-Jun-2023, with unknown strength and dose) via unknown route in unknown administration site as prophylactic vaccination with no reported adverse event (expired product administered) (Latency: same day). It was reported "Caller clarified that a total of 8 patients received the expired Tenivac, but she does not have any patient information at this time." This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 28.09.2023
- Impfdatum
- 20.09.2023
- Beginn
- 20.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Wrong product administered
Symptomtext
patient received an expired dose of tenivac, when he was suppose to receive a dose of Tdap with no reported adverse event; patient received an expired dose of tenivac, when he was suppose to receive a dose of Tdap with no reported adverse event; Initial information received on 20-Sep-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 48 years old male patient who received an expired dose of diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac], when he was supposed to receive a dose of Diphtheria, Tetanus And Acellular Pertussis Vaccine with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 20-Sep-2023, the patient received a dose 0.5 ml of suspect Diphtheria-2/Tetanus-5 Adsorbed Toxoids No Preservative Adult Suspension for injection lot U7092AA expiry date: 24-Jun-2023 via intramuscular route in the deltoid not specified for prophylactic vaccination (immunization) and patient received an expired dose of tenivac, when he was supposed to receive a dose of Diphtheria, Tetanus And Acellular Pertussis Vaccine with no reported adverse event (expired product administered) (wrong product administered). Action taken was not applicable. At time of reporting, the outcome was Unknown for the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 38,0
- Geschlecht
- M
- Eingang
- 10.09.2023
- Impfdatum
- 09.09.2023
- Beginn
- 09.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Administration of expired vaccine to patient. No adverse signs or symptoms observed or reported by patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 10.09.2023
- Impfdatum
- 09.09.2023
- Beginn
- 09.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Administration of expired vaccine to patient. No adverse signs or symptoms observed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 10.09.2023
- Impfdatum
- 09.09.2023
- Beginn
- 09.09.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Administration of expired vaccination to patient. No significant signs or symptoms noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 05.09.2023
- Impfdatum
- 30.08.2023
- Beginn
- 30.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
administration of expired vaccine to a patient with no reported adverse event; Initial information received on 30-Aug-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age and unknown gender patient who had administration of expired diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] vaccine with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 30-Aug-2023, the patient received an expired dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult Suspension for injection at a dose of 0.5 mL (lot U7092AA, expiry date- 24-JUN-2023) via unknown route in unknown administration site for Immunization with no reported adverse event (expired product administered) (latency- same day). Reportedly, Pharmacist requested information on what is recommended if a patient was inadvertently administered an expired TENIVAC. He did not know if the patient had received any concomitant vaccines and did not have information on where on the body the vaccine was administered. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 11.08.2023
- Impfdatum
- 02.08.2023
- Beginn
- 02.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
staff member misinterpret expiration date on Tenivac it's listed as 24Jun23 staff member thought means June 23, 2024; vaccine was administered to a patient with no reported adverse event; Initial information received on 09-Aug-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 70 years old male patient who was administered expired diphtheria-2/ tetanus-5 adsorbed toxoids no preservative adult [Tenivac] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 02-Aug-2023, the patient received an expired dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult, suspension for injection (batch number: U7092AA; expiry date: 24-Jun-2023) via intramuscular route in the left deltoid for Immunization (as the staff member misinterpret expiration date on tenivac it's listed as 24jun23 staff member thought means june 23, 2024) with no reported adverse event (expired product administered) (same day latency). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event staff member misinterpret expiration date on tenivac it's listed as 24jun23 staff member thought means june 23, 2024; vaccine was administered to a patient with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- M
- Eingang
- 04.08.2023
- Impfdatum
- 28.06.2023
- Beginn
- 28.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
patient was administered tenivac 28Jun2023 but it expired the 24Jun2023 with no reported adverse event; Initial information received on 02-Aug-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves Adult male patient who was administered tenivac 28jun2023, but it expired the 24jun2023 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 28-Jun-2023, the patient received 0.5 ml dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult, Suspension for injection lot U7092AA, expiry date: 24-Jun-2023 via intramuscular route in the left deltoid for immunization (strength: unknown), but it expired the 24jun2023 with no reported adverse event (expired product administered) (latency same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event expired product administered. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 60,0
- Geschlecht
- U
- Eingang
- 01.08.2023
- Impfdatum
- 26.06.2023
- Beginn
- 26.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
administration of expired TENIVAC with no reported adverse event; Initial information received on 24-Jul-2023 regarding an unsolicited valid non-serious case received from a nurse. This case involves 60 years old and unknown gender patient who had administration of expired diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 26-JUN-2023, the patient received a standard expired dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult Suspension for injection at a dose of 0.5 ml once (lot U7092AA, expiry date- 24-JUN-2023) via unknown route in unknown administration site for immunization with no reported adverse event (expired product administered)(latency- same day). Reportedly, A nurse manager reported that they have administered an expired TENIVAC to a patient. caller asks if the administered dose is still valid and if not, should they be administering another dose to the patient. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2023SA228035:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 76,0
- Geschlecht
- U
- Eingang
- 31.07.2023
- Impfdatum
- 24.07.2023
- Beginn
- 24.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
administered an expired TENIVAC to a patient with no reported adverse event; Initial information received on 24-Jul-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 76 years old and unknown gender patient who was administered an expired diphtheria-2/ tetanus-5 adsorbed toxoids no preservative adult [Tenivac] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 24-Jul-2023, the patient received 0.5 mL dose of suspect diphtheria-2/ tetanus-5 adsorbed toxoids no preservative adult, Suspension for injection (batch number: U7092AA; Expiry date: 24-Jun-2023) via unknown route in unknown administration site for Immunization, with no reported adverse event (expired product administered) (same day latency). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event administered an expired tenivac to a patient with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2023SA228200:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 7,0
- Geschlecht
- F
- Eingang
- 20.07.2023
- Impfdatum
- 27.06.2023
- Beginn
- 27.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
injected with an expired Tenivac 3 days after it has expired for Immunization, with no reported adverse event; Initial information received on 13-Jul-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 7 years old female patient who was injected with an expired diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] 3 days after it has expired for immunization, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included polio vaccine inact 3V (vero) (IPOL) for Prophylactic vaccination (immunization). On 27-Jun-2023, the patient received 0.5 mL dose 1 of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult, suspension for injection (batch number: U7092AA; expiry date: 24-Jun-2023) via intramuscular route in the arm (left arm as per patient mother) for Immunization 3 days after it has expired with no reported adverse event (expired product administered) (same day latency). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event injected with an expired tenivac 3 days after it has expired for immunization, with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- -
- Geschlecht
- U
- Eingang
- 19.07.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
administration of an expired product to a patient with no reported adverse event; Initial information was received on 14-Jul-2023 regarding an unsolicited valid non-serious case received from an other health professional (Pharmacist). This case involves an unknown age patient of unknown gender who received an expired product of diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] with no reported adverse event The patient's past medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided. On an unknown date, the patient received a dose of an expired suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult Suspension for injection (lot number: U7092AA, expiration date: 24-Jun-2023, strength, route, administration site: Unknown) for Immunization (immunisation) with no reported adverse event (expired product administered) (latency: same day). It was reported that "The product displayed an expiration date of 24-Jun-23. The caller believed that this meant that the vaccine expired 23-Jun-2024. It was administered to a patient. After speaking with the pharmacy technician, the pharmacist came on the line. She explained their confusion in reading the expiration date." No lab data reported. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event administration of an expired product to a patient with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 9,0
- Geschlecht
- F
- Eingang
- 13.07.2023
- Impfdatum
- 10.07.2023
- Beginn
- 10.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Medication error
No adverse event
Symptomtext
expired dose of Tenivac was administered to a patient, with no reported adverse event; Initial information was received on 10-Jul-2023 regarding an unsolicited valid non-serious case received from a consumer/non-health-care professional. This case involves 9 years old female patient who reported that expired dose of diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult (Tenivac) was administered to a patient, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included hepatitis a vaccine (hepa [hepatitis a vaccine]) for prophylactic vaccination; and polio vaccine (polio) for prophylactic vaccination. On 10-Jul-2023, the patient received a dose of 0.5 ml of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult(Suspension for injection) (lot U7092AA, Expiry date: 24-Jun-2023) (strength was unknown) via intramuscular route in the left deltoid for Immunization. On 10-Jul-2023 the patient administrated expired dose of tenivac was administered to a patient, with no reported adverse event (expired product administered) (latency : same day) following the administration of diphtheria-2/tetanus-5 adsorbed toxoids NO PRESERVATIVE ADULT. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event expired dose of tenivac was administered to a patient, with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 08.07.2023
- Impfdatum
- 06.07.2023
- Beginn
- 06.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
expired dose of a TENIVAC administered with no reported adverse event; Initial information received on 06-Jul-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 57 years old male patient for whom expired dose of a diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] was administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 06-Jul-2023, the patient received a standard expired dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult Suspension for injection at a dose of 0.5ML (lot U7092AA, expiry date- 24-JUN-2023) via unknown route in the left deltoid for Immunization with no reported adverse event (expired product administered) (latency- same day). Caller would like to know if the dose should be readministered? Action taken was not applicable. At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 05.07.2023
- Impfdatum
- 30.06.2023
- Beginn
- 30.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
patient who received TENIVAC that was expired on 24Jun2023 and was administered today, the 30Jun2023 with no reported adverse event; Initial information received on 30-Jun-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 51 years old female patient received diphtheria-2/tetanus-5 Adsorbed Toxoids No Preservative Adult [Tenivac] that was expired on 24jun2023 and was administered today, the 30jun2023 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 30-Jun-2023, the patient received a 0.5 ml dose of suspect diphtheria-2/tetanus-5 Adsorbed Toxoids No Preservative Adult (strength: not reported; expiry date: 30Jun-2023 and lot U7092AA) via intramuscular route in the right deltoid for Immunization and received was expired vaccine with no reported adverse event (expired product administered) (latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 29.06.2023
- Impfdatum
- 28.06.2023
- Beginn
- 28.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Expired vaccine was administered. Expired June 24, 2023. The expiration on the syinge was printed as "23JUN24" and was interpreted as June 23, 2024.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- N/A
- Allergien
- Penicillin allergy
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 28.06.2023
- Impfdatum
- 26.06.2023
- Beginn
- 26.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
patient that received a tenivac vaccine that was two days past its expiration date with no reported adverse event; Initial information received on 26-Jun-2023 regarding an unsolicited valid non-serious case received from an other health professional. This case involves a 65 years old female patient where she received diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] vaccine that was two days past its expiration date with no reported adverse event. The patient's past medical history, medical treatment(s) and family history were not provided. No concomitant vaccines were administered. On 26-Jun-2023, the patient received 0.5 mL (TOTAL) Booster dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult Suspension for injection single-dose prefilled syringe (batch number- U7092AA and expiration date- 24-Jun-2023) via intramuscular route in the left deltoid (strength: not provided) for Immunization. On 26-Jun-2023 the patient received a tenivac vaccine that was two days past its expiration date with no reported adverse event (expired product administered) (latency- same day) following the administration of diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult. Action taken- not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 27.06.2023
- Impfdatum
- 27.06.2023
- Beginn
- 27.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Vaccine administered was expired by 3 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 26.06.2023
- Impfdatum
- 26.06.2023
- Beginn
- 26.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
expired vaccine given. EXP:24JUN23
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Asthma , Eczema
- Andere Medikamente
- Albuterol
- Allergien
- Cephalexin, Lexapro
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 24.03.2023
- Impfdatum
- 03.03.2023
- Beginn
- 03.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Symptomtext
TENIVAC and Infanrix were administered to patient with no adverse event; Initial information regarding an unsolicited valid non-serious case received via medical assistant on 15-Mar-2023 processed along with live follow-up of same. number: 01534286, 01533938. This case involves 16 years old female patient who experienced Diphtheria and Tetanus Toxoids (Tenivac) and Diphtheria Vaccine Toxoid, Pertussis Vaccine Acellular 3-Component, Tetanus Vaccine Toxoid (Infanrix) were administered to patient with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Last menstrual period was 26-feb-2023. Concomitant medications included Polio Vaccine INACT 3V (Vero) (Ipol) for Prophylactic vaccination; Measles Vaccine, Mumps Vaccine, Rubella Vaccine (MMR) for Prophylactic vaccination; Varicella Zoster Vaccine (Varicella Vaccine) for Prophylactic vaccination; and Diphtheria Vaccine Toxoid, Pertussis Vaccine Acellular 5-Component, Tetanus Vaccine Toxoid (Adacel) for Prophylactic vaccination. On 03-Mar-2023, the patient received suspect INFANRIX not produced by Sanofi Pasteur at (unknown: formulation, strength, dose, lot number, route in unknown administration site) for prophylactic vaccination and on same day, the patient received suspect Tenivac vaccine Suspension for injection at dose 0.3ml once (lot: U7092AA, expiry date: 24-Jun-2023) via intramuscular route in the left deltoid for prophylactic vaccination with no adverse event (extra dose administered) at same day latency. Action taken with was not applicable. No corrective treatment was received for the event. At time of reporting, the outcome was Unknown for the event extra dose administered. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- IPOL [POLIO VACCINE INACT 3V (VERO)]; MMR; VARICELLA VACCINE; ADACEL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 26,0
- Geschlecht
- M
- Eingang
- 04.11.2022
- Impfdatum
- 06.09.2022
- Beginn
- 06.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood pressure decreased
Cold sweat
Pallor
Symptomtext
Donor received the Tetanus Diphtheria Booster at 11:43 am, 7 mintes later, at 11:50m, the donor was pale and clamy.. Donor's blood pressure dropped to 90/62 from 112/80 that was taken earlier that day. Donor was provided Propel water and taken to an exam room to rest. After drinking the water, donor's blood pressure rose to 106/76. Donor left the cente with no incident.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blood pressure decreased
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None reported.
- Vorgeschichte
- History of hypertension, hypothyroidsim and anxiety
- Andere Medikamente
- Donor reported taking Prozac, HCTZ, Levothyroxine and Trazadon
- Allergien
- None reported.
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 70,0
- Geschlecht
- U
- Eingang
- 22.10.2022
- Impfdatum
- 10.08.2022
- Beginn
- 10.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Poor quality product administered
Product storage error
Symptomtext
medication error due to temperature excursion that exceeded the stability data and Tenivac was administered to patient, with no reported adverse event; medication error due to temperature excursion that exceeded the stability data and Tenivac was administered to patient, with no reported adverse event; Initial information received on 12-Oct-2022 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional (hcp). This case involves a 70-year-old (unknown gender) patient, reported a medication error due to temperature excursion that exceeded the stability data and DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [Tenivac] was administered to patient, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 10-Aug-2022, the patient received suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT strength: standard (formulation, dose , route: unknown) (lot number: U7092AA and expiry date: 24-Jun-2023) in unknown administration site for Immunization and on the same day tenivac was administered to patient, with no reported adverse event (poor quality product administered) and medication error due to temperature excursion that exceeded the stability data, with no reported adverse event (product storage error) (unknown latency). Action taken with DIPHTHERIA AND TETANUS TOXOIDS (TENIVAC) was not applicable for both events. At time of reporting, the outcome was Unknown for both events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 0,5
- Geschlecht
- F
- Eingang
- 08.08.2022
- Impfdatum
- 28.07.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental exposure to product
No adverse event
Product administered to patient of inappropriate age
Symptomtext
tenivac was inadvertently given to a 6 month old patient with no adverse event; Initial information received on 28-Jul-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 6 months old female patient and it was reported that tenivac (DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT) was inadvertently given to a 6 month old patient with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, HEPATITIS B VACCINE RHBSAG (YEAST), PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (PEDIARIX) for Immunisation; PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Immunisation; ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) for Immunisation; and HIB VACCINE CONJ (OMPC) (PEDVAXHIB) for Immunisation. On 28-Jul-2022, the patient received a dose of 0.5 ml of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT (formulation, strength: unknown) lot U7092AA, expiration date: 24-Jun-2023, via intramuscular route in the left thigh as immunization. On 28-JUL-2022 the tenivac was inadvertently given to a 6 month old patient with no adverse event (accidental exposure to product) same day following the administration of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental exposure to product
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- PEDIARIX; PREVNAR 13; ROTAVIRUS VACCINE; PEDVAXHIB
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 14.07.2022
- Impfdatum
- 24.05.2022
- Beginn
- 24.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a sub-optimal COVID-19 vaccine due to a storage and handling error. Vaccine was stored in a regular freezer prior to being refrigerated and them administered. Requested that a VAERS form be submitted for this patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 04.05.2022
- Impfdatum
- 01.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bursitis
Musculoskeletal discomfort
Shoulder injury related to vaccine administration
Symptomtext
SIRVA, specifically bursitis. Have been taking various anti-inflammatories and resting affected shoulder.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bursitis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 30.03.2022
- Impfdatum
- 29.11.2021
- Beginn
- 05.01.2022
- Tage bis Beginn
- 37,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Gastric banding
Ileostomy
Intestinal mass
Oophorectomy
Salpingectomy
Symptomtext
Mass of small intestine - Procedures: laparoscopic removal of gastric band with open ileocolic resection and bilateral salpingectomy and oophorectomy. Recovery in hospital. Hospital admission within 6 weeks of receiving the COVID vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Gastric banding
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -